Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

• Status: Completed
• Trial end date: 2009-03-09
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of British Columbia
• Treatments: Androgen Antagonists; Androgens; Minoxidil; Spironolactone

Criteria

Inclusion Criteria:

• Subjects must be premenopausal women older than 18 with female pattern hair loss.

Exclusion Criteria:

• Androgen excess

• Other scalp or hair disorders

• Contraindications to spironolactone treatment, especially pregnancy, electrolyte imbalances, history of breast cancer, or intake of interfering drugs

• Contraindications to minoxidil treatment, especially patients who are allergic to this treatment or have a history of low blood pressure or irregular heart beats